Recovery of Renal Impairment by Bortezomib-Doxorubicin-Dexamethasone (BDD) in Multiple Myeloma (MM) Patients with Acute Renal Failure. Results from an Ongoing Phase II Study.

H Ludwig; Z Adam; R Hajek; Richard Greil; F Keil; N Zojer; J Thaler; H Gisslinger; A Lang

Recovery of Renal Impairment by Bortezomib-Doxorubicin-Dexamethasone (BDD) in Multiple Myeloma (MM) Patients with Acute Renal Failure. Results from an Ongoing Phase II Study.

H Ludwig, Z Adam, R Hajek, Richard Greil, F Keil, N Zojer, J Thaler, H Gisslinger, A Lang

Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center

Research output: Contribution to conference › Poster

Original language	English
Publication status	Published - 2007
Event	49th Annual Meeting of American Society of Hematology (ASH) - Atlanta, Georgia, United States Duration: 8 Dec 2007 → 11 Dec 2007

Conference with scientific content

Conference with scientific content	49th Annual Meeting of American Society of Hematology (ASH)
Country/Territory	United States
City	Atlanta, Georgia
Period	8/12/07 → 11/12/07

1 Abstract (Journal)

Recovery of Renal Impairment by Bortezomib-Doxorubicin-Dexamethasone (BDD) in Multiple Myeloma (MM) Patients with Acute Renal Failure. Results from an Ongoing Phase II Study.
Ludwig, H., Adam, Z., Hajek, R., Greil, R., Keil, F., Zojer, N., Thaler, J., Gisslinger, H. & Lang, A., 2007, In: BLOOD . 110, p. 3603
Research output: Contribution to journal › Abstract (Journal) › peer-review

Cite this

Ludwig, H., Adam, Z., Hajek, R., Greil, R., Keil, F., Zojer, N., Thaler, J., Gisslinger, H., & Lang, A. (2007). Recovery of Renal Impairment by Bortezomib-Doxorubicin-Dexamethasone (BDD) in Multiple Myeloma (MM) Patients with Acute Renal Failure. Results from an Ongoing Phase II Study.. Poster session presented at 49th Annual Meeting of American Society of Hematology (ASH), Atlanta, Georgia, United States.

@conference{49ecf39ecf434d179182490f37c26eb5,

title = "Recovery of Renal Impairment by Bortezomib-Doxorubicin-Dexamethasone (BDD) in Multiple Myeloma (MM) Patients with Acute Renal Failure. Results from an Ongoing Phase II Study.",

author = "H Ludwig and Z Adam and R Hajek and Richard Greil and F Keil and N Zojer and J Thaler and H Gisslinger and A Lang",

year = "2007",

language = "English",

note = "49th Annual Meeting of American Society of Hematology (ASH) ; Conference date: 08-12-2007 Through 11-12-2007",

}

Ludwig, H, Adam, Z, Hajek, R, Greil, R, Keil, F, Zojer, N, Thaler, J, Gisslinger, H & Lang, A 2007, 'Recovery of Renal Impairment by Bortezomib-Doxorubicin-Dexamethasone (BDD) in Multiple Myeloma (MM) Patients with Acute Renal Failure. Results from an Ongoing Phase II Study.', 49th Annual Meeting of American Society of Hematology (ASH), Atlanta, Georgia, United States, 8/12/07 - 11/12/07.

Recovery of Renal Impairment by Bortezomib-Doxorubicin-Dexamethasone (BDD) in Multiple Myeloma (MM) Patients with Acute Renal Failure. Results from an Ongoing Phase II Study. / Ludwig, H; Adam, Z; Hajek, R et al.
2007. Poster session presented at 49th Annual Meeting of American Society of Hematology (ASH), Atlanta, Georgia, United States.

Research output: Contribution to conference › Poster

TY - CONF

T1 - Recovery of Renal Impairment by Bortezomib-Doxorubicin-Dexamethasone (BDD) in Multiple Myeloma (MM) Patients with Acute Renal Failure. Results from an Ongoing Phase II Study.

AU - Ludwig, H

AU - Adam, Z

AU - Hajek, R

AU - Greil, Richard

AU - Keil, F

AU - Zojer, N

AU - Thaler, J

AU - Gisslinger, H

AU - Lang, A

PY - 2007

Y1 - 2007

M3 - Poster

T2 - 49th Annual Meeting of American Society of Hematology (ASH)

Y2 - 8 December 2007 through 11 December 2007

ER -